Agenus Announces Public Offering of Common Stock

05-02-2014 Business Wire HealthComments (0)

AgenusBiotechnologyPharmaceutical

Agenus Inc. (Nasdaq: AGEN) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by Agenus. William Blair & Company, L.L.C. is acting as sole book-running manager for the offering. Agenus intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the amount sold to cover over-allotments, if any. The offering is subject to mar

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top